this example describes the rationale behind the choice of two human light chain v - genes , one gene of the kappa type and one gene of the lambda type , that are used as a proof of concept for light chain expressing transgenic mice . de wildt et al . 1999 ( de wildt et al . ( 1999 ), j . mol . biol . 285 ( 3 ): 895 ) analyzed the expression of human light chains in peripheral igg - positive b - cells . based on these data , igkv1 - 39 ( o12 ) and iglv2 - 14 ( 2a2 ) were chosen as light chains as they were well represented in the b - cell repertoire . the j - segment sequence of the light chains has been chosen based upon sequences as presented in genbank aba26122 for igkv1 - 39 ( b . j . rabquer , s . l . smithson , a . k . shriner and m . a . j . westerink ) and genbank aaf20450 for iglv2 - 14 ( o . ignatovich , i . m . tomlinson , a . v . popov , m . bruggemann and g . j . winter , j . mol . biol . 294 ( 2 ): 457 - 465 ( 1999 )). all framework segments are converted into germline amino acid sequences to provide the lowest immunogenicity possible in potential clinical applications . obtaining mouse heavy chain v - genes that pair with human igkv1 - 39 gene segment to form functional antibody binding sites this example describes the identification of mouse heavy chain v - genes that are capable of pairing with a single , rearranged human germline igkv1 - 39 / j region . a spleen vh repertoire from mice that were immunized with tetanus toxoid was cloned in a phage display fab vector with a single human igkv1 - 39 - c kappa light chain and subjected to panning against tetanus toxoid . clones obtained after a single round of panning were analyzed for their binding specificity . the murine vh genes encoding tetanus toxoid - specific fab fragments were subjected to sequence analysis to identify unique clones and assign vh , dh and jh utilization . many of the protocols described here are standard protocols for the construction of phage display libraries and the panning of phages for binding to an antigen of interest and described in antibody phage display : methods and protocols ( editor ( s ): philippa m . o &# 39 ; brien and robert aitken ). balb / c mice received one immunization with tetanus toxoid and were boosted after six weeks with tetanus toxoid . preparation of spleen cell suspension . after dissection , the spleen was washed with pbs and transferred to a 60 mm petri dish with 20 ml pbs . a syringe capped with 20 ml pbs and a g20 needle was used to repeatedly flush the spleen . after washing the flushed cells with pbs , the cells were carefully brought into suspension using 20 ml pbs and left on a bench for five minutes to separate the splenocytes from the debris and cell clusters . the splenocytes suspension was transferred on top of a ficoll - paque ™ plus - filled tube and processed according to the manufacturer &# 39 ; s procedures for lymphocyte isolation ( amersham biosciences ). after isolation and pelleting of lymphocytes , the cells were suspended in trizol ls reagent ( invitrogen ) for the isolation of total rna according to the accompanying manufacturer &# 39 ; s protocol and subjected to reverse transcription reaction using 1 microgram of rna , superscript iii rt in combination with dt20 according to manufacturer &# 39 ; s procedures ( invitrogen ). the cdna was amplified in a pcr reaction using primer combinations that allow the amplification of approximately 110 different murine v - genes belonging to 15 vh families ( table 1 ; refseq ng — 005838 ; thiebe et al . 1999 , european journal of immunology 29 : 2072 - 2081 ). in the first round , primer combinations that bind to the 5 ′ end of the v - genes and 3 ′ end of the j regions were used . in the second round , pcr products that were generated with the mjh - rev2 primer were amplified in order to introduce modifications in the 3 ′ region to enable efficient cloning of the products . in the last round of amplification , all pcr products were amplified using primers that introduce a sfii restriction site at the 5 ′ end and a bsteii restriction site at the 3 ′ end ( see fig1 and 2 , and table 1 ). reaction conditions for 1st round pcr : four different reactions combining all 25 forward primers ( mvh1 to mvh25 , table 1 and fig2 ) and one reverse primer per reaction ( mjh - rev1 , mjh - rev2 , mjh - rev3 or mjh - rev4 ; see table 1 and fig2 ). fifty microliters pcr volumes were composed of 2 microliters cdna ( from rt reactions ), 10 microliters 5 * phusion polymerase hf buffer , 40 nm of each of the 25 forward primers ( total concentration of 1 micromolar ), 1 micromolar reverse primer , 1 microliter 10 mm dntp stock , 1 . 25 unit phusion polymerase and sterile mq water . the thermocycler program consisted of a touch down program : one cycle 98 ° c . for 30 seconds , 30 cycles 98 ° c . for ten seconds , 58 ° c . decreasing 0 . 2 ° c . per cycle ten seconds , 72 ° c . 20 seconds and one cycle 72 ° c . for three minutes . the second round pcr program was set up only for the products of the first pcr that contain the mjh - rev2 primer : two different reactions combining either the extmvh - 1 or extmvh - 2 primers ( table 1 and fig2 ) in combination with the reverse primer extmjh - rev2int ( table 1 and fig2 ). fifty microliters pcr volumes were composed of 50 ng pcr product ( from first pcr round ), 10 microliters 5 * phusion polymerase hf buffer , 500 nm of each forward primer , 1 micromolar reverse primer , 1 microliter 10 mm dntp stock , 1 . 25 unit phusion polymerase and sterile mq water . the thermocycler program consisted of a touch down program followed by a regular amplification step : one cycle 98 ° c . for 30 seconds , ten cycles 98 ° c . for ten seconds , 65 ° c . decreasing 1 . 5 ° c . per cycle ten seconds , 72 ° c . 20 seconds , ten cycles 98 ° c . for ten seconds , 55 ° c . ten seconds , 72 ° c . 20 seconds and one cycle 72 ° c . for three minutes . the third round pcr program was setup as described in fig2 . fifty microliters pcr volumes were composed of 50 ng pcr product ( from earlier pcr rounds , fig2 ), 10 microliters 5 * phusion polymerase hf buffer , 1 micromolar forward primer ( table 1 and fig2 ), 1 micromolar reverse primer , 1 microliter 10 mm dntp stock , 1 . 25 unit phusion polymerase and sterile mq water . the program consists of a touch down program followed by a regular amplification step : one cycle 98 ° c . for 30 seconds , ten cycles 98 ° c . for ten seconds , 65 ° c . decreasing 1 . 5 ° c . per cycle ten seconds , 72 ° c . 20 seconds , ten cycles 98 ° c . for ten seconds , 55 ° c . ten seconds , 72 ° c . 20 seconds and one cycle 72 ° c . for three minutes . after pcr amplifications , all pcr products were gel purified using qiaex ii according to the manufacturer &# 39 ; s protocols . purified products were digested with bsteii and sfii in two steps . first 1 microgram of dna was digested in 100 microliters reactions consisting of 10 microliters of 10 * neb buffer 3 ( new england biolabs ), 1 microliter 100 * bsa , 12 . 5 unit bsteii and sterile water for six hours at 60 ° c . in a stove . the products were purified using qiaquick pcr purification kit from qiagen according to the manual instructions and eluted in 40 microliters water . next all products were further digested with sfii in 100 microliters reactions consisting of 10 microliters of 10 * neb buffer 2 ( new england biolabs ), 1 microliter 100 * bsa , 12 . 5 unit sfii and sterile water for 12 hours at 50 ° c . in a stove . the digested fragments were purified by qiaquick gel extraction kit following gel separation on a 20 cm 1 . 5 % agarose tbe plus ethidium bromide gel at 80 v . 100 micrograms of the acceptor vector ( mv1043 , fig3 and 12 ) was digested with 50 units eco91i in 600 microliters under standard conditions ( tango buffer ) and next purified on a 0 . 9 % agarose gel . after a second digestion step under prescribed conditions with 400 units sfii in 500 microliters for 12 hours , 100 units bsrgi were added for three hours at 50 ° c . each pcr product was ligated separately according to the following scheme : 70 ng digested pcr products , 300 ng digested acceptor vector , 100 units t4 ligase ( neb ), 1 * ligase buffer in 30 microliters for 16 hours at 12 ° c . the ligation reactions were purified with phenol / chloroform / isoamyl alcohol extractions followed by glycogen precipitations ( sigma aldrich # g1767 ) according to the manufacturer &# 39 ; s protocol and finally dissolved in 25 microliters sterile water . the purified ligation products were transformed by electroporation using 1200 microliters tg1 electrocompetent bacteria ( stratagene # 200123 ) per ligation batch and plated on lb carbenicillin plates containing 4 % glucose . libraries were harvested by scraping the bacteria in 50 ml lb carbenicillin . after centrifugation at 2000 g for 20 minutes at 4 ° c ., the bacterial pellets were resuspended carefully in 2 ml ice cold 2 * ty / 30 % glycerol on ice water and frozen on dry ice / ethanol before storage at − 80 ° c . libraries were grown and harvested according to procedures as described by kramer et al . 2003 ( kramer et al . ( 2003 ), nucleic acids res . 31 ( 11 ): e59 ) using vcsm13 ( stratagene ) as helper phage strain . tetanus toxoid was dissolved in pbs in a concentration of 2 μg / ml and coated to maxisorp ™ nunc - immuno tube ( nunc 444474 ) overnight at 4 ° c . after discarding the coating solution , the tubes were blocked with 2 % skim milk ( elk ) in pbs ( blocking buffer ) for one hour at rt . in parallel , 0 . 5 ml of the phage library was mixed with 1 ml blocking buffer and incubated for 20 minutes at room temperature . after blocking the phages , the phage solution was added to the tetanus toxoid - coated tubes and incubated for two hours at rt on a slowly rotating platform to allow binding . next , the tubes were washed ten times with pbs / 0 . 05 % tween ™- 20 detergent followed by phage elution by an incubation with 1 ml 50 mm glycine - hcl ph 2 . 2 ten minutes at rt on rotating wheel and directly followed by neutralization of the harvested eluent with 0 . 5 ml 1 m tris - hcl ph 7 . 5 . five ml xl1 - blue mrf ( stratagene ) culture at o . d . 0 . 4 was added to the harvested phage solution and incubated for 30 minutes at 37 ° c . without shaking to allow infection of the phages . bacteria were plated on carbenicillin / tetracycline 4 % glucose 2 * ty plates and grown overnight at 37 ° c . phages were grown and processed as described by kramer et al . 2003 ( kramer et al . 2003 , nucleic acids res . 31 ( 11 ): e59 ) using vcsm13 as helper phage strain . elisa plates were coated with 100 microliters tetanus toxoid per well at a concentration of 2 micrograms / ml in pbs overnight at 4 ° c . plates coated with 100 microliters thyroglobulin at a concentration of 2 micrograms / ml in pbs were used as a negative control . wells were emptied , dried by tapping on a paper towel , filled completely with pbs - 4 % skimmed milk ( elk ) and incubated for one hour at room temperature to block the wells . after discarding the block solution , phage minipreps pre - mixed with 50 μl blocking solution were added and incubated for one hour at rt . next five washing steps with pbs - 0 . 05 % tween - 20 removed unbound phages . bound phages were detected by incubating the wells with 100 microliters anti - m13 - hrp antibody conjugate ( diluted 1 / 5000 in blocking buffer ) for one hour at room temperature . free antibody was removed by repeating the washing steps as described above , followed by tmb substrate incubation until color development was visible . the reaction was stopped by adding 100 microliters of 2 m h 2 so 4 per well and analyzed on an elisa reader at 450 nm emission wavelength ( table 2 ). higher numbers indicate stronger signals and thus higher incidence of specific binding of the phage - fab complex . clones that gave signals at least three times above the background signal ( table 2 ) were propagated , used for dna miniprep procedures ( see procedures qiagen miniprep manual ) and subjected to nucleotide sequence analysis . sequencing was performed according to the big dye 1 . 1 kit accompanying manual ( applied biosystems ) using a reverse primer ( ch1_rev1 , table 1 ) recognizing a 5 ′ sequence of the ch1 region of the human igg1 heavy chain ( present in the fab display vector mv1043 , fig3 and 12 ). mouse vh sequences of 28 tetanus toxoid binding clones are depicted in table 3 . the results show that the selected murine vh genes belong to different gene families , and different individual members from these gene families are able to pair with the rearranged human igkv1 - 39 / j vh region to form functional tetanus toxoid - specific antibody binding sites . from the sequence analyses , it was concluded that the murine vh regions utilize a diversity of dh and jh gene segments . this example describes the silencing of the mouse endogenous kappa light chain locus . the endogenous kappa locus is modified by homologous recombination in es cells , followed by the introduction of genetically modified es cells in mouse embryos to obtain genetically adapted offspring . a vector that contains an assembled nucleotide sequence consisting of a part comprising the j - region to 338 bp downstream of the j5 gene segment fused to a sequence ending 3 ′ of the 3 ′ ck enhancer is used for homologous recombination in es cells . the assembled sequence is used to delete a genomic dna fragment spanning from 3 ′ of the jk region to just 3 ′ of the 3 ′ ck enhancer . as a consequence of this procedure , the ck constant gene , the 3 ′ enhancer and some intergenic regions are removed ( see fig4 and 18 a - b ). a vector that received 4 . 5 - 8 kb flanking arms on the 3 ′ and 5 ′ end fused to the deletion segment was used for targeted homologous recombination in an es cell line . both arms were obtained by pcr means ensuring maximum homology . the targeting strategy allows generation of constitutive ko allele . the mouse genomic sequence encompassing the igk intronic enhancer , igk constant region and the igk 3 ′ enhancer was replaced with a puror cassette , which was flanked by f3 sites and inserted downstream of the jk elements . f1p - mediated removal of the selection marker resulted in a constitutive ko allele . the replacement of the igk miek - igk c - igk 3 ′ e genomic region ( approximately 10 kb ) with a f3 - puro cassette ( approx . 3 kb ) was likely to decrease the efficiency of homologous recombination . therefore , the arms of homology were extended accordingly and more es cell colonies were analyzed after transfection in order to identify homologous recombinant clones . the generation of genetically modified es cells was essentially performed as described ( seibler et al . ( 2003 ), nucleic acids res . february 15 ; 31 ( 4 ): e12 ). see also example 14 for a detailed description . the production of mice by tetraploid embryo complementation using genetically modified es cells was essentially performed as described ( eggan et al ., pnas 98 : 6209 - 6214 ; j . seibler et al . ( 2003 ), nucleic acids res . february 15 ; 31 ( 4 ): e12 ; hogan et al . ( 1994 ), summary of mouse development , manipulating the mouse embryo , cold spring harbor laboratory press , cold spring harbor n . y ., pp . 253 - 289 ). this example describes the silencing of the mouse endogenous lambda light chain locus . the endogenous lambda locus is modified by homologous recombination in es cells followed by the introduction of genetically modified es cells in mouse embryos to obtain genetically adapted offspring . two regions of the murine lambda locus that together contain all functional lambda v regions are subject to deletion . the first region targeted for homologous recombination - based deletion is a region that is located 408 bp upstream of the start site of the iglv2 gene segment and ends 215 bp downstream of iglv3 gene segment , including the intergenic sequence stretch between these iglv gene segments . the second region that is subject to a deletion involves the iglv1 gene segment consisting of a fragment spanning from 392 bp upstream to 171 bp downstream of the iglv1 gene segment . as a consequence of these two deletion steps , all functional v - lambda genes segments are deleted , rendering the locus functionally inactive ( fig5 and 19 a - b ). vectors that received 3 - 9 . 6 kb flanking arms on the 3 ′ and 5 ′ end fused to the deletion segment were used for targeted homologous recombination in an es cell line . both arms were obtained by pcr means ensuring maximum homology . in a first step , the mouse genomic sequence encompassing the igl v2 - v3 regions were replaced with a puror cassette flanked by f3 sites , which yields a constitutive ko allele after flp - mediated removal of selection marker ( see fig1 a ). in a second step , the mouse genomic sequence encompassing the igl v1 region was replaced with a neo cassette in es cell clones which already carried a deletion of the igl v2 - v3 regions ( see fig1 b ). the selection marker ( neor ) was flanked by frt sites . a constitutive ko allele was obtained after flp - mediated removal of selection markers . the generation of genetically modified es cells was essentially performed as described ( j . seibler , b . zevnik , b . küter - luks , s . andreas , h . kern , t . hennek , a . rode , c . heimann , n . faust , g . kauselmann , m . schoor , r . jaenisch , k . rajewsky , r . kühn , f . schwenk ( 2003 ), nucleic acids res ., february 15 ; 31 ( 4 ): e12 ). see also , example 14 for a detailed description . to show that both targeting events occurred on the same chromosome several double targeted clones were selected for the in vitro deletion with pcmv c31deltacpg . the clones were expanded under antibiotic pressure on a mitotically inactivated feeder layer comprised of mouse embryonic fibroblasts in dmem high glucose medium containing 20 % fcs ( pan ) and 1200μ / ml leukemia inhibitory factor ( millipore esg 1107 ). 1 × 10 7 cells from each clone were electroporated with 20 μg of circular pcmv c31deltacpg at 240 v and 500 μf and plated on four 10 cm dishes each . two to three days after electroporation , cells were harvested and analyzed by pcr . primers used were : pcr reactions were performed in mixtures comprising 5 μl pcr buffer 10 × ( invitrogen ), 2 μl mgcl 2 ( 50 mm ), 1 μl dntps ( 10 mm ), 1 μl first primer ( 5 μm ), 1 μl second primer ( 5 μm ), 0 . 4 μl taq ( 5 u / ul , invitrogen ), 37 . 6 μl h 2 o , and 2 μl dna . the program used was 95 ° c . for five minutes ; followed by 35 cycles of 95 ° c . for 30 seconds ; 60 ° c . for 30 seconds ; 72 ° c . for 1 minute ; followed by 72 ° c . for ten minutes . the production of mice by tetraploid embryo complementation using genetically modified es cells was essentially performed as described ( eggan et al ., pnas 98 : 6209 - 6214 ; j . seibler , b . zevnik , b . küter - luks , s . andreas , h . kern , t . hennek , a . rode , c . heimann , n . faust , g . kauselmann , m . schoor , r . jaenisch , k . rajewsky , r . kuhn , and f . schwenk ( 2003 ), nucleic acids res ., february 15 ; 31 ( 4 ): e12 ; hogan et al . ( cold spring harbor laboratory press , cold spring harbor n . y . ), pp . 253 - 289 ). construction of the caggs expression insert based on a rearranged human germline igkv1 - 39 / j - ck gene ( igkv1 - 39 / j - ck ) this example describes the construction of a caggs expression cassette incorporating the rearranged human germline igkv1 - 39 / j region . this insert expression cassette encompasses cloning sites , a kozak sequence , a leader sequence containing an intron , an open reading frame of the rearranged igkv1 - 39 region , a rat ck constant region from allele a and a translational stop sequence ( igkv1 - 39 / j - ck ; fig6 ). the primary construct consists of naturally occurring sequences and has been analyzed and optimized by removing undesired cis acting elements like internal tata - boxes , poly adenylation signals , chi - sites , ribosomal entry sites , at - rich or gc - rich sequence stretches , are -, ins - and crs sequence elements , repeat sequences , rna secondary structures , ( cryptic ) splice donor and acceptor sites and splice branch points ( geneart gmbh ). in addition , the codon usage in the open reading frame regions is optimized for expression in mice . the intron sequence is unchanged and thus represents the sequence identical to the coding part of the human igkv1 - 39 leader intron . at the 5 ′ end of the expression cassette , a noti site was introduced and on the 3 ′ site a nhei site . both sites are used for cloning in the caggs expression module . after gene assembly according to methods used by geneart , the insert is digested with noti - nhei and cloned into the expression module containing a caggs promoter , a stopper sequence flanked by loxp sites (“ foxed ”), a polyadenylation signal sequence and , at the 5 ′ and 3 ′ end , sequences to facilitate homologous recombination into the rosa26 locus of mouse es cell lines . promoter and / or cdna fragments were amplified by pcr , confirmed by sequencing and / or cloned directly from delivered plasmids into an rmce exchange vector harboring the indicated features . a schematic drawing and the confirmed sequence of the final targeting vector pcaggs - igvk1 - 39 are shown in fig1 a and 13b . the targeting strategy is depicted in fig1 c . caggs expression insert based on the rearranged germline iglv2 - 14 / j v lambda region ( iglv2 - 14 / j - ck ) this example describes the sequence and insertion of an expression cassette incorporating the rearranged germline iglv2 - 14 / j v lambda region . this insert encompasses cloning sites , a kozak sequence , a leader sequence containing an intron , an open reading frame of the rearranged iglv2 - 14 / j region , a rat ck constant region from allele a and a translational stop sequence ( iglv2 - 14 / j - ck ; fig7 ). the primary construct consists of naturally - occurring sequences and has been analyzed and optimized by removing undesired cis acting elements like : internal tata - boxes , poly adenylation signals , chi - sites , ribosomal entry sites , at - rich or gc - rich sequence stretches , are -, ins - and crs sequence elements , repeat sequences , rna secondary structures , ( cryptic ) splice donor and acceptor sites and splice branch points ( geneart gmbh ). in addition , the codon usage in the open reading frame regions was optimized for expression in mice . the intron sequence is unchanged and thus represents the sequence identical to the human igkv1 - 39 leader intron . at the 5 ′ end of the expression cassette , a noti site was introduced and on the 3 ′ site a nhei site . both sites are used for cloning in the caggs expression module as described by taconicartemis . after gene assembly according to methods used by geneart , the insert was digested with noti - nhei and cloned into the expression module containing a caggs promoter , a stopper sequence flanked by loxp sites (“ foxed ”), a polyadenylation signal sequence and , at the 5 ′ and 3 ′ end , sequences to facilitate homologous recombination into the rosa26 locus of mouse es cell lines . to construct the final rosa26 rmce targeting vector , promoter and / or cdna fragments were amplified by pcr . amplified products were confirmed by sequencing and / or cloned directly from delivered plasmids into an rmce exchange vector harboring the indicated features . a schematic drawing and the confirmed sequence of the final targeting vector pcaggs - igvl2 - 14 is shown in fig1 a and 15b . the targeting strategy is depicted in fig1 c . this example describes a method to verify that the igkv1 - 39 / j - ck constructs described in example 5 enable expression and detection of the igkv1 - 39 / j - ck l chain in hek293 cells . the igkv1 - 39 / j insert ( fig6 ) was modified at the 5 ′ end by changing the noti site into a sali site . this change is required for cloning of the product into the expression cassette plasmid pselect - hygro ( invivogen ). the caggs expression insert igkv1 - 39 / j - ck and pselect - hygro were digested with sali and nhei , ligated and used to transform competent xl1 - blue cells using standard techniques . colonies were picked and dna purified using qiagen midi - prep columns according to the manufacturer &# 39 ; s procedures . the resulting light chain ( lc ) expressing vector named 0817676_pselect — 0815426 was used to transfect hek293 cells with fugene6 ( roche ) according to the manufacturer &# 39 ; s protocols . supernatants were screened for the presence of igkv1 - 39 / j - ck light chains by elisa and western blot using anti - rat - ck antibodies ( beckton dickinson # 550336 and 553871 ) and protocols used in the art . the vh of anti - tetanus toxoid ( tt ) igg mg1494 was cloned into igg expression vector mv1056 using restriction sites sfii and bsteii . the resulting clone was sequence verified . hek293t cells were transfected with five different vector combinations as shown in table 4 ( see example 8 for details of vector 0817678_pselect — 0815427 ). supernatants were harvested and igg concentrations determined ( see table 4 ). no igg could be detected for supernatants a and b containing light chain only as expected ( detection antibody recognized fc part of igg ). igg concentration in supernatants c and d was comparable to that of positive control supernatant e , indicating correct expression of the light chain constructs . binding to tt was analyzed by elisa to check functionality of the produced antibodies , using hemoglobin as negative control antigen . no tt - specific binding could be detected for supernatants a and b containing light chain only , as expected . tt - specific binding for supernatants c and d was at least as good as for positive control supernatant e , confirming correct expression of the light chain constructs and functional assembly with heavy chain . antibodies were detected not only using an anti - human igg secondary antibody , but also an anti - rat ckappa light chain secondary antibody . the results confirm that the anti - rat ckappa antibody ( bd pharmingen # 553871 , clone mrk - 1 ) recognizes the light chain expressed by the pselect vectors . supernatants were analyzed by non - reducing sds - page and western blot ( not shown ). detection using an anti - human igg heavy chain antibody did not show bands for supernatants a and b containing light chain only , as expected . results for supernatants c and d were comparable to positive control supernatant e , with a band close to the 170 kd marker as expected for intact igg . additional lower molecular weight bands were observed as well for supernatants c , d and e , which might represent degradation products , igg fragments resulting from ( partial ) reduction and / or irrelevant protein bands due to non - specific binding of the detection antibody . detection using an anti - rat ckappa light chain antibody showed a band close to the 26 kd marker for supernatants a and b , as expected for light chain only . this band was much more intense for a compared to b , indicating that the free igkv1 - 39 light chain may be better expressed and / or more stable than the free iglv2 - 14 light chain . no bands were detected for control supernatant e as expected , since the expressed igg contains a human ckappa light chain . for supernatants c and d , expected bands close to the 170 kd marker were observed ; lower molecular weight bands were also observed , but to a lesser extent than above using the anti - human igg antibody . in conclusion , transfection of the light chain expression constructs combined with the heavy chain of anti - tetanus toxoid ( tt ) igg mg1494 resulted in igg production comparable to the positive control construct for both the pselect kappa and lambda light chain constructs . both igg productions yielded elisa signals in a tt elisa that were better than or comparable to the control igg . sds - page and western blot analysis confirmed the presence of intact igg . the tested anti - rat ckappa antibody worked efficiently in both elisa and western blot . culture supernatant from cells transfected with light chain constructs only did not result in detectable igg production nor in detectable tt - specific binding , while free light chain was detected on western blot . this example describes a method to verify that the iglv2 - 14 / j constructs described in example 6 enable expression and detection of the iglv2 - 14 / j - ck l chain in hek293 cells . the iglv2 - 14 / j - ck insert ( fig7 ) was modified at the 5 ′ end by changing the noti site into a sali site . this change is required for cloning of the product into the expression cassette plasmid pselect - hygro ( invivogen ). the caggs expression insert iglv2 - 14 / j - ck and pselect - hygro were digested with sali and nhei ligated and used to transform competentxl1 - blue cells using standard techniques . colonies were picked and dna purified using qiagen midi - prep columns according to the manufacturer &# 39 ; s procedures . the resulting light chain ( lc ) expressing vector named 0817678_pselect — 0815427 was used to transfect hek293 cells with fugene6 ( roche ) according to the manufacturer &# 39 ; s protocols . supernatants were screened for the presence of iglv2 - 14 / j - ck light chains by elisa and western blot using anti - rat - ck antibodies ( becton dickinson # 550336 and 553871 ) and protocols used in the art . see example 7 for details and results . construction of a vk promoter - driven expression construct containing an igkv1 - 39 / j insert and multiple enhancer elements derived from the murine ck locus ( vkp - igkv1 - 39 / j - ck ; vkp - o12 ) this example describes the construction of an expression cassette that contains relevant elements to enable b - cell and developmental / differentiation stage - specific expression of the rearranged human igkv1 - 39 vk region , based on the igkv1 - 39 vk promoter region , leader containing an intron , germline v - gene , cdr3 , igkj segment , mouse intergenic region located between jk and ck , rat ck allele a open reading frame , and a mouse intergenic fragment from the 3 ′ end of the mouse ck gene ending just 3 ′ of the 3 ′ ck enhancer . optimized open reading frames of the leader , igkv1 - 39 rearranged gene , and rat ck allele a gene , as described in example 5 , was used for the construction of the expression cassette . the vk promoter region was obtained by gene synthesis procedures ( geneart , gmbh ) and is almost identical to the sequence of the human igkv1 - 39 region between − 500 bp and the atg ( start site ) of the gene . the only deviation from the natural sequence is the introduction of a gccaccatgg kozak sequence ( seq id no : 102 ) at the atg ( start ) site in order to promote translation . a genomic fragment from a mouse bac clone ( taconicartemis ) is used as the basis for the introduction of individual elements . this fragment is identical to the sequence of the mouse vk locus starting with the intron donor site located directly 3 ′ of the jk5 region and ending just 3 ′ of the 3 ′ ck enhancer and covers approximately 12 . 5 kb . the final construct contains from 5 ′ to 3 ′ end the following elements : human genomic igkv1 - 39 promoter ( 500 bp ), a kozak sequence , a human igkv1 - 39 leader part 1 ( optimized ), a human igkv1 - 39 leader intron , a human igkv1 - 39 leader part 2 ( optimized ), a human igkv1 - 39 germline gene ( optimized ), a human j - region ( optimized ), a mouse intergenic region including the intron enhancer element , a rat ( rattus norvegicus ) kappa constant region ( optimized ), and a mouse intergenic region including the 3 ′ kappa enhancer . the elements of this expression cassette are shown in fig8 and named vkp - igkv1 - 39 / j - ck ( vkp - o12 ). an outline of the pvkp - o12 vector and the targeting strategy is depicted in fig2 a and 21a . the vector was introduced into es cells following standard procedures ( see example 14 ). construction of a vk promoter - driven expression construct containing an iglv2 - 14 / j clone and multiple ck locus - derived enhancer elements ( vkp - iglvl2 - 14 / j - ck ; vkp - 2a2 ) this example describes the same construct as described in example 9 , except that the igkv1 - 39 gene and j - region are replaced by the optimized human iglv2 - 14 germline gene including a unique v - j region ( vkp - iglv2 - 14 / j - ck ; vkp - 2a2 ; fig9 ). construction of a vk promoter - driven expression construct containing an igkv1 - 39 clone lacking the ck intron enhancer element ( vkp - igkv1 - 39 / j - ck - δ1 ; vkp - o12 - del1 ) the construct described in example 9 was modified by removing the ck intron enhancer element , located in the intergenic region between the human j region and the rat ck region by standard pcr modification and dna cloning methodologies ( geneart , gmbh ). the resulting expression cassette is shown in fig1 and named vkp - igkv1 - 39 / j - ck - δ1 ( vkp - o12 - del1 ). an outline of the pvkp - o12 - del1 vector and the targeting strategy is depicted in fig2 b and 21b . the vector was introduced into es cells following standard procedures ( see example 14 ). construction of a vk promoter - driven expression construct containing an igkv1 - 39 clone lacking the ck intron enhancer element and a truncated 3 ′ ck enhancer element ( vkp - igkv1 - 39 / j - ck - a2 ; vkp - o12 - del2 ) the construct described in example 11 was modified by truncating the 3 ′ ck enhancer element and deleting part of the intergenic region 3 ′ of the rat ck gene , to remove potential inhibitory elements . this was achieved by removing the intergenic sequence between an ecorv site ( located 3 ′ of the rat ck gene ) and the ncoi site present in the 3 ′ enhancer ( 5993 bp ) and further removing the sequence between the 3 ′ enhancer bstxi site and the bstxi site 3 ′ of the 3 ′ enhancer ( 474 bp ) using standard methods . the resulting expression cassette is shown in fig1 and named vkp - igkv1 - 39 / j - ck - a2 ( vkp - o12 - del2 ). an outline of the pvkp - o12 - del2 vector and the targeting strategy is depicted in fig2 c and 21c . the vector was introduced into es cells following standard procedures ( see example 14 ). the constructs described in examples 9 - 12 are tested for their ability to produce light chain proteins in the myeloma cell lines mpc11 ( atcc ccl167 ), b - cell lymphoma wehi231 ( atcc crl - 1702 ), the t - cell lymphoma el4 ( atcc tib - 39 ) and in hek293 ( atcc crl1573 ). the enhancer and promoter elements in the construct enable expression in the b - cell lines but not in cell lines derived from other tissues . after transfection of the cell lines using purified linearized dna and fugene6 ( roche ) cells are cultured for transient expression . cells and supernatant are harvested and subjected to sds - page analysis followed by western blotting using a specific anti - rat - c - kappa antibody . supernatants are analyzed in elisa for secreted l chains using the anti - rat ck antibody ( beckton dickinson # 550336 ). all constructs as described in examples 3 , 4 , 5 , 6 , 9 , 10 , 11 and 12 were used to generate individual stable transgenic es lines by means of homologous recombination . the methods for generation of transgenic es lines via homologous recombination are known in the field ( e . g ., eggan et al ., pnas 98 : 6209 - 6214 ; j . seibler , b . zevnik , b . küter - luks , s . andreas , h . kern , t . hennek , a . rode , c . heimann , n . faust , g . kauselmann , m . schoor , r . jaenisch , k . rajewsky , r . kuhn , f . schwenk ( 2003 ), nucleic acids res ., february 15 ; 31 ( 4 ): e12 ; hogan et al . ( cold spring harbor laboratory press , cold spring harbor n . y . ), pp . 253 - 289 ). for all constructs described in examples 5 and 6 , and examples 9 - 12 , the rmce es cell line ( derived from mouse strain 129s6b6f1 - gt ( rosa ) 26sortm10arte ) was grown on a mitotically inactivated feeder layer comprised of mouse embryonic fibroblasts ( mef ) in dmem high glucose medium containing 15 % fbs ( pan 1302 - p220821 ). leukemia inhibitory factor ( chemicon esg 1107 ) was added to the medium at a concentration of 900 u / ml . for manipulation , 2 × 10 5 es - cells were plated on 3 . 5 cm dishes in 2 ml medium . directly before transfection , 2 ml fresh medium was added to the cells . three μl fugene6 reagent ( roche ; catalog no . 1 814 443 ) was mixed with 100 μl serum free medium ( optimem i with glutamax i ; invitrogen ; catalog no . 51985 - 035 ) and incubated for five minutes . one hundred μl of the fugene / optimem solution was added to 2 μg circular vector and 2 μg caggs - flp and incubated for 20 minutes . this transfection complex was added dropwise to the cells and mixed . fresh medium was added to the cells the following day . from day 2 onwards , the medium was replaced daily with medium containing 250 μg / ml g418 ( geneticin ; invitrogen ; catalog no . 10131 - 019 ). seven days after transfection , single clones were isolated , expanded , and molecular analyzed by southern blotting according to standard procedures . for each construct , analysis of multiple clones by restriction enzyme digestion of genomic dna of single clones followed by hybridization with 5 ′ probes , 3 ′ probes , and internal probes resulted in clones that comprised a correct , single insertion at the correct position in the rosa26 locus . an example is provided in fig1 a - c . all es cell lines that were generated and verified for their modifications as described in example 14 were used to generate stable transgenic mice by means of tetraploid recombination . the methods are known in the field . in general , after administration of hormones , superovulated balb / c females were mated with balb / c males . blastocysts were isolated from the uterus at dpc 3 . 5 . for microinjection , blastocysts were placed in a drop of dmem with 15 % fcs under mineral oil . a flat tip , piezo actuated microinjection - pipette with an internal diameter of 12 - 15 micrometers was used to inject 10 - 15 targeted c57bl / 6 n . tac es cells into each blastocyst . after recovery , injected blastocysts were transferred to each uterine horn of 2 . 5 days post coitum , pseudopregnant nmri females . chimerism was measured in chimeras ( g0 ) by coat color contribution of es cells to the balb / c host ( black / white ). highly chimeric mice were bred to strain c57bl / 6 females . depending on the project requirements , the c57bl / 6 mating partners are non - mutant ( w ) or mutant for the presence of a recombinase gene ( flp - deleter or cre - deleter or creer inducible deleter or combination of flp - deleter / creer ). germline transmission was identified by the presence of black , strain c57bl / 6 , offspring ( g1 ). for example , esc clone igvk1 - 39 2683 8 ( see examples 5 and 14 ) was injected in a total of 62 blastocysts in three independent experiments . three litters were obtained with a total of six pups . all pups were chimeric . three heterozygous offspring pups were obtained that were used for further crossing . esc clone kappa 2692 a - c10 ( see examples 3 and 14 ) was injected in a total of 54 blastocysts in three independent experiments . three litters were obtained with a total of eleven pups , of which ten were chimeric . eight heterozygous offspring pups were obtained that were used for further crossing . esc clone kappa 2692 b - c1 ( see examples 3 and 14 ) was injected in a total of 51 blastocysts in three independent experiments . two litters were obtained with a total of six pups , of which four were chimeric . three heterozygous offspring pups were obtained that were used for further crossing . this example describes the breeding for obtaining mice that contain transgenic expression cassettes as described example 14 and knock - out mice in which the endogenous lambda and kappa loci have been silenced . the localization of v - lambda on chromosome 16 and cd19 on chromosome 7 allow standard breeding procedures . the breeding of the co - localized vk locus and rosa26 locus on chromosome 6 with a distance of about 24 cm requires special attention during the screening as only a percentage of the offspring shows crossover in a way that both modifications are brought together on one chromosome . all four loci have to be combined in a single mouse strain that is homo - or heterozygous for cd19 - cre ( not described ) and modified rosa26 transgene and homozygous for the other loci . breeding is performed by standard breeding and screening techniques as appropriate and offered by commercial breeding companies ( e . g ., taconicartemis ). primary and booster immunization of mice are performed using standard protocols . to validate the transgenic expression of human rearranged vκ o12 ( igkv1 - 39 )— rat cκ light chains ( see examples 5 , 14 - 16 ) in b cells from cd19 - huvκ1 mice and to assess its impact on vh repertoire size , diversity of vh family usage and v ( d ) j recombination after immunization , the cd19 - huvκ1 transgenic mice are immunized with tetanus toxin vaccine ( tt vaccine ) and vh sequence diversity of randomly picked clones from cd19 - huvκ1 mice are compared with tt - immunized wt mice and cd19 - cre huvk1 negative littermates . data on the shm frequency of the human vκ o12 transgene in the immunized mice are obtained . a diverse collection of at least 40 tt - specific , clonally - unrelated mabs containing the human vκ o12 are recovered from cd19 - huvκ1 mice by phage display . for this , three adult cd19 - huvκ1 mice are vaccinated with tt vaccine using standard immunization procedures . after immunization , serum titers are measured using tt specific elisa ( tt : statens serum institute , art . no . 2674 ) and spleen suspensions subjected to cell sorting by the facs procedure after staining with a rat cκ - specific monoclonal antibody to isolate transgenic b cells ( clone rg7 / 9 . 1 ; bd pharmingen # 553901 , lot # 06548 ). rna from rat cκ - positive b cells are extracted and the resulting cdna material used for library building and shm analysis . the standard monoclonal mouse anti - rat cκ antibody ( clone rg7 / 9 . 1 ; bd pharmingen # 553901 , lot # 06548 ) is used in facs analysis of transgene expressing b cells ( meyer et al . ( 1996 ), int . immunol . 8 : 1561 ). the clone rg7 / 9 . 1 antibody reacts with a monotypic ( common ) kappa chain determinant . this anti - rat cκ antibody ( clone rg7 / 9 . 1 ( bd pharmingen # 553901 , lot # 06548 ) is labeled with r - phycoerythrin ( pe ) using the lynx rapid conjugation kit according to the manufacturer &# 39 ; s instructions for facs analysis and sorting . the labeled antibody is firstly tested by flow cytometry for binding to rat cκ - containing functional light chain proteins produced into transiently transfected hek - 293t cells ; the un - conjugated antibody serves as a positive control . two other antibodies shown to bind to rat cκ by elisa and western - blot ( see example 7 ) are tested as well by flow cytometry . fab - phage display library building is carried out with a set of optimized degenerate pcr primers designed to amplify c57bl / 6 vh genes ; the minimal library size is 10 6 clones , and minimal insert frequency is 80 %. the vector used , mv1043 ( fig3 and 12 ), contains the human vκ o12 fused to a human cκ region . the rat cκ is therefore exchanged for the human counterpart in the library generation process . before selection , vh sequencing of 96 randomly picked clones is performed to validate vh repertoire diversity that is compared to diversity obtained from an unselected library previously generated using the same procedures from balb / c mice immunized with tt . a library from c57b1 / 6 wt mice that are immunized in the same way allows diversity comparison between two preselected libraries sharing the same vaccine and the same genetic background . several independent selections are performed on tt coated in immunotubes . variables that may be included are selections using biotinylated antigens in solution or selections on captured tt . based on the number and diversity of elisa - positive clones obtained in the first selections , decisions on additional rounds of selection are made . clones are considered positive when & gt ; 3 × positive over a negative control clone . positive clones are analyzed by elisa against a panel of negative control antigens to verify antigen specificity . the aim is to identify at least 40 unique vh regions , as based on unique cdr3 sequences and v h dj h rearrangements . amplification of the cdna material from rat cκ - positive sorted b cells is performed with a pcr forward primer specific to the human leader sequence and a pcr reverse primer specific to the rat cκ sequence , in a region not redundant with the mouse cκ sequence , as reported in a recent study ( brady et al . ( 2006 ), jim 315 : 61 ). primer combinations and annealing temperatures are firstly tested on cdna from hek - 293t cells transfected with 0817676_pselect — 0815426 = pselect vector with igkv1 - 39 dna cassette ( see example 7 ). the amplification products is cloned in pjet - 1 vector and after xl1 - blue transformation , 96 colonies are sequenced for assessing vl shm frequency by direct comparison to the vκ o12 ( igkv1 - 39 ) germline sequence . the r / s ratio method , as described in our study on human tt - specific antibodies ( de kruif et al . ( 2009 ), j . mol . biol . 387 : 548 ) allows discrimination between random mutations and antigen - driven mutations that occurred on vl sequences . this example describes the use of antibodies and flow cytometry to analyze b cell populations in primary ( bone marrow ) and secondary ( spleen , peritoneal ) lymphoid organs and blood . methods and reagents are described in middendorp et al . ( 2002 ), j . immunol . 168 : 2695 ; and middendorp et al . ( 2004 ), j . immunol . 172 : 1371 . for analysis of early b cell development in bone marrow , cells were surface stained with combinations of antibodies ( becton dickinson ) specific for b220 , cd19 , cd25 , igm , igd , mouse ckappa , mouse clambda and rat ckappa to detect pro - b cells , pre - b cells , large pre - b cells , early and late immature b cells and recirculating b cell populations expressing the transgene on their surface . dapi staining ( invitrogen ) was included to exclude dead cells from the analysis and fc block ( becton dickinson ) to inhibit antibody interaction with fc receptors on myeloid cells . for analysis of surface transgene expression on b cell populations in peripheral lymphoid organs and blood , cells were stained with combinations of antibodies ( becton dickinson ) specific for b220 , cd5 , cd19 , cd21 , cd23 , igm , igd , mouse ckappa , mouse clambda and rat ckappa . dapi staining was included to exclude dead cells from the analysis and fc block to inhibit antibody interaction with fc receptors on myeloid cells . in addition , combinations of antibodies ( becton dickinson ) specific for cd3 , cd4 , cd11b , cd11c and nk1 . 1 were included to determine if transgene expression occurred in cell types outside of the b cell compartment . three mice heterozygous for the human igkv1 - 39 / rat ckappa transgene and heterozygous for the cd19 - cre transgene on a c57bl6 background ( huvk1 / cd19 - cre ) were analyzed . as controls for the facs analysis , three littermate mice wild - type for the human igkv1 - 39 / rat ckappa transgene and heterozygous for the cd19 - cre transgene on a c57bl6 background ( cd19 - cre ) and two c57bl6 / ntac mice ( wt ) were included . all animals were allowed to acclimatize in the animal facility for one week before analysis and all mice were male and six weeks of age . lymphocytes were isolated from the femurs , spleens , peritoneal cavity and blood of mice using conventional techniques as previously described ( middendorp et al . ( 2002 ), j . immunol . 168 : 2695 ; and middendorp et al . ( 2004 ), j . immunol . 172 : 1371 ). antibodies were pre - combined as shown in table 10 and staining was carried out in 96 - well plates . incubation with the pe - conjugated anti - rat c kappa ( described above ) was carried out before staining with the rat anti - murine antibodies to avoid non - specific binding . after completion of cell staining , labeled cells were analyzed on a becton dickinson lsr ii facs machine and the acquired data analyzed with flowjo software ( v6 . 4 . 7 ). transgenic mice were similar in weight , appearance and activity to wild - type mice . no gross anatomical alterations were observed during the harvesting of tissues . no difference was observed in the numbers of b cells in the bone marrow ( bm ) and spleen ( table 11 ) or in the numbers of b cells , t cells and myeloid cells in peripheral organs between transgenic and wild - type mice . in addition , the frequency or proportion of the cells in the different lymphocyte developmental pathways was not altered in transgenic mice when compared to wild - type mice . thus in the double transgenic ( huvk1 / cd19 - cre ) and transgenic ( cd19 - cre ) mice lymphoid and most importantly b cell development was indistinguishable from wild - type mice . in the peripheral lymphoid organs , staining with the transgene specific antibody ( anti - ratckappa - pe ) was only observed in the b cell populations . t cell , myeloid cell and nk cell populations were all negative for surface expression of the transgene in the spleen ( fig2 ). in contrast , in cells stained with the pan b cell markers b220 and cd19 all cells were shifted to the right in the facs plot indicating cell surface expression of the transgene ( fig2 ). a similar transgene - specific staining was measured in cd5 + b1 cells of the peritoneum , a developmentally distinct population of b cells ( fig2 ). differentiation of b cells from multilineage precursors to mature b cells occurs in the bone marrow . in the lymphocytes analyzed from the bone marrow , extracellular and transgene expression was not detectable in the earliest b cell progenitors the pro - and pre - b cell consistent with the pattern of normal light chain expression ( fig2 a - b ). transgene expression first becomes detectable in immature b cells , the developmental stage at which the germline murine light chain undergoes rearrangement and is expressed at the cell surface in the context of the preselected heavy chain ( fig2 a - b ). consistent with the staining in the spleen transgenic light chain expression is also detected on mature recirculating b cells ( fig2 a - b ). thus the cd19 - cre driven expression of the transgene is consistent with the normal pattern of light chain expression . the staining with the endogenous light chain - specific antibody is more intense than that of the transgene - specific light chain antibody . this may indicate a higher expression level of the endogenous light chain , a more sensitive staining with the endogenous light chain - specific antibody or a combination of both . importantly , the intensity of the surface expression of the transgenic light chain is correlated with both endogenous light chain and igm surface expression as observed in staining of circulating b cells in the blood ( fig2 ). thus , overall this analysis demonstrates that expression of the human igkv1 - 39 / ckappa transgene is restricted to the b cell compartment and the temporal regulation of its expression is similar to the endogenous kappa and lambda light chains resulting in normal development of all b cell populations . the apparent lower level of expression of the transgene could be explained by the strength of the promoter in comparison to the promoter and enhancers present on endogenous light chain genes or by a delay in transgene expression that gives the endogenous light chains a competitive advantage in pairing with the rearranged heavy chain . this is consistent with the observation that as b cells mature the relative intensity of transgene staining increases compared to the endogenous light chains . in addition , the observation that b cells numbers are normal and that every surface ig + b cell co - expresses an endogenous and transgenic light chain supports the conclusion that the igkv1 - 39 variable region is capable of pairing with a normal repertoire of different murine heavy chain variable regions . we conclude from this analysis that insertion of the igkv1 - 39 / rat ckappa transgene driven by the cd19 - cre activated caggs promoter in the rosa locus facilitates timely and b cell - specific expression of the transgene and that the transgene is capable of pairing with a normal repertoire of murine heavy chains . the protein sequence of igkv1 - 39 ( fig1 , human germline igkv1 - 39 / j protein ) was scanned for the presence of putative hla class ii restricted epitopes , also known as t h - epitopes . for this , algonomics &# 39 ; epibase ® platform was applied to igkv1 - 39 . in short , the platform analyzes the hla binding specificities of all possible 10 - mer peptides derived from a target sequence ( desmet et al . ( 1992 ), nature 356 : 539 - 542 ; desmet et al . ( 1997 ), faseb j . 11 : 164 - 172 ; desmet et al . ( 2002 ), proteins 48 : 31 - 43 ; desmet et al . ( 2005 ), proteins 58 : 53 - 69 ). profiling is done at the allotype level for 20 drb1 , 7 drb3 / 4 / 5 , 13 dq and 7 dp , i . e ., 47 hla class ii receptors in total ( see table 5 ). epibase ® calculates a quantitative estimate of the free energy of binding δg bind of a peptide for each of the 47 hla class ii receptors . these data were then further processed as follows : free energies were converted into kd - values through δg bind = rt ln ( kd ). peptides were classified as strong ( s ), medium ( m ), weak and non ( n ) binders . the following cutoffs were applied : peptides corresponding to self - peptides were treated separately . the list of self - peptides was taken from 293 antibody germline sequences . they are referred to as “ germline - filtered ” peptides . s - and m - peptides are mapped onto the target sequence in so - called epitope maps ; s - affinities are plotted quantitatively ; m - values are presented qualitatively . as a general overview of the results , table 6 lists the number of strong and medium binders in the analyzed proteins , for the groups of hla class ii receptors corresponding to the drb1 , dq , dp and drb3 / 4 / 5 genes . counting was done separately for strong and medium affinity binders . peptides binding to multiple allotypes of the same group were counted as one . values between brackets refer to germline - filtered peptides . in table 7 , the sequence is shown in a format suitable for experimental work . the sequence is broken down in consecutive 15 - mers overlapping by 12 residues . for each 15 - mer , the promiscuity is listed ( the number of allotypes out of a total of 47 for which the 15 - mer contains a critical binder ), as well as the implied serotypes . the epibase ® profile and epitope maps are shown in fig1 a - c and 17 . it was concluded that igkv1 - 39 contains no strong non - self drb1 binders . typically , significantly more binders were found for drb1 than for other hla genes . this is in agreement with experimental evidence that allotypes belonging to the drb1 group are more potent peptide binders . medium strength epitopes for drb1 allotypes are expected to contribute to the population response , and cannot be disregarded . again , no non - self drb1 binders were found in igkv1 - 39 . in the humoral response raised against an antigen , the observed t h cell activation / proliferation is generally interpreted in terms of the drb 1 specificity . however , one cannot ignore the possible contribution of the drb3 / 4 / 5 , dq and dp genes . given the lower expression levels of these genes as compared to drb1 , the focus was on the class of strong epitopes for drb3 / 4 / 5 , dq and dp . “ critical epitopes ” are those epitopes that are strong binders for any drb1 , drb3 / 4 / 5 , dq or dp allotype or are medium binders for drb1 . igkv1 - 39 contains no strong or medium non - self binders for drb3 / 4 / 5 , dq , or dp . a number of peptides are also present in germline sequences ( values between brackets in table 6 ). such peptides may very well bind to hla but they are assumed to be self and , hence , non - immunogenic . in total , six strong and 16 medium germline - filtered drb1 binders were found in igkv1 - 39 . framework region 1 up to framework region 3 is an exact match for germline v - segment vki 2 - 1 -( 1 ) o12 ( vbase ), a . k . a . igkv1 - 39 * 01 ( imgt ). framework region 4 is an exact match for germline j - segment jk1 ( v - base ) a . k . a . igkj1 * 01 ( imgt ). it is hardly surprising that these segments do not contain any non - self epitopes . there is a great demand for antibody discovery platforms that yield therapeutic antibodies that are thermodynamically stable and give good expression yields . these characteristics are important in ensuring the stability of the drug substance during production and after injection of the drug product into the patient . in addition good expression yields impact directly on the cost of drug manufacture and thus pricing , patient access and profitability . virtually all therapeutic antibodies in clinical use today are composed of human igg1 and kappa constant regions but use different heavy and light chain variable regions that confer specificity . human variable heavy and light chain domains can be divided into families that have greater than 80 % sequence divergence . when rearranged examples of these families in germline configuration are combined and compared for stability and yield it is clear that the gene families are not equal in terms of biophysical properties . in particular v h 3 , v h 1 and v h 5 have favourable stability for the heavy chains and vk1 and vk3 have the best stability and yield of light chains . in addition when mutations are introduced as part of the somatic hypermutation process they can interfere with v h / v l pairing . to assess the effect that different light chain genes with different rates of mutation have on the production characteristics of a fixed v h chain , a fab phage display library was built of light chains ( kappa and lambda ) from six naïve healthy donors combined with a panel of 44 tt binding heavy chains from immunized donors . after one round of selection tt binding fab clones were isolated . several of these shared the same v h gene as the tt clone pg1433 in combination with different light chains . the fab light chain fragments were recloned into a kappa expression vector and transfected in combination with dna encoding the heavy chain of pg1433 into 293 cells and specific igg production measured by elisa . as demonstrated in table 8 the selected clones containing pg1433 v h combined with different light chains had between five - and ten - fold lower protein expression pg1433 v h combined with igkv1 - 39 . note that all of the light chains contained amino acid mutations within their coding regions that might disrupt v h paring and reduce production stability . thus , in addition to reducing the chances of unwanted immunogenicity , it is expected that the use of the light chain igkv1 - 39 without mutations contributes to improved production stability and yields of various specificity - contributing v h genes . indeed stable clones generated by the transfection of different v h genes all paired with igkv1 - 39 are able to be passaged extensively and still retain robust production characteristics as shown in table 9 . transgenic mice described herein are crossed with mice that already contain a human vh locus . examples of appropriate mice comprising a human vh locus are disclosed in taylor et al . ( 1992 ), nucleic acids res . 20 : 6287 - 95 ; lonberg et al . ( 1994 ), nature 368 : 856 - 9 ; green et al . ( 1994 ), nat . genet . 7 : 13 - 21 ; dechiara et al . ( 2009 ), methods mol . biol . 530 : 311 - 24 .). after crossing and selecting for mice that are at least heterozygous for the igkv1 - 39 transgene and the human vh locus , selected mice are immunized with a target . vh genes are harvested as described hereinabove . this method has the advantage that the vh genes are already fully human and thus do not require humanization . isolation , characterization , oligoclonics formatting and production of antibodies targeting human il6 for treatment of chronic inflammatory diseases such as rheumatoid arthritis a spleen vh repertoire from transgenic mice that are immunized with human recombinant il6 is cloned in a phage display fab vector with a single human igkv1 - 39 - c kappa light chain ( identical to the mouse transgene ) and subjected to panning against the immunogen human il6 . clones that are obtained after two to four rounds of panning are analyzed for their binding specificity . vh genes encoding il6 - specific fab fragments are subjected to sequence analysis to identify unique clones and assign vh , dh and jh utilization . the fab fragments are reformatted as igg1 molecules and transiently expressed . unique clones are then grouped based on non - competition in binding assays and subjected to affinity and functional analysis . the most potent anti - il6 igg1 mabs are subsequently expressed as combinations of two , three , four or five heavy chains comprising different vh - regions in the oligoclonics format , together with one igkv1 - 39 - c - based kappa light chain and tested in vitro for complex formation with il - 6 . the oligoclonics are also tested in vivo for clearance of human il - 6 from mice . an oligoclonic with the most potent clearance activity is chosen and the murine vh genes humanized according to conventional methods . the humanized igg1 are transfected into a mammalian cell line to generate a stable clone . an optimal subclone is selected for the generation of a master cell bank and the generation of clinical trial material . many of the protocols described here are standard protocols for the construction of phage display libraries and the panning of phages for binding to an antigen of interest and are described , for example , in antibody phage display : methods and protocols ( 2002 ), editor ( s ) philippa m . o &# 39 ; brien , robert aitken , humana press , totowa , n . j ., usa . transgenic mice receive three immunizations with human il6 every two weeks using the adjuvant sigma titermax according to manufacturer &# 39 ; s instructions . three days after the last immunization , spleens and lymphnodes from the mice are removed and passed through a 70 micron filter into a tube containing pbs ph 7 . 4 to generate a single cell suspension . after washing and pelleting of lymphocytes , cells are suspended in trizol ls reagent ( invitrogen ) for the isolation of total rna according to the manufacturer &# 39 ; s protocol and subjected to reverse transcription reaction using 1 microgram of rna , superscript iii rt in combination with dt20 according to manufacturer &# 39 ; s procedures ( invitrogen ). the generation of fab phage display libraries is carried out as described in example 2 . human recombinant il6 is dissolved in pbs in a concentration of 5 μg / ml and coated to maxisorp ™ nunc - immuno tube ( nunc 444474 ) overnight at 4 ° c . after discarding the coating solution , the tubes are blocked with 2 % skim milk ( elk ) in pbs ( blocking buffer ) for one hour at room temperature ( rt ). in parallel , 0 . 5 ml of the phage library is mixed with 1 ml blocking buffer and incubated for 20 minutes at room temperature . after blocking the phages , the phage solution is added to the il6 - coated tubes and incubated for two hours at rt on a slowly rotating platform to allow binding . next , the tubes are washed ten times with pbs / 0 . 05 % tween ™- 20 detergent followed by phage elution by incubating with 1 ml 50 mm glycine - hcl ph 2 . 2 ten minutes at rt on rotating wheel and directly followed by neutralization of the harvested eluent with 0 . 5 ml 1 m tris - hcl ph 7 . 5 . a 5 ml xl1 - blue mrf ( stratagene ) culture at o . d . 0 . 4 is added to the harvested phage solution and incubated for 30 minutes at 37 ° c . without shaking to allow infection of the phages . bacteria are plated on carbenicillin / tetracycline 4 % glucose 2 * ty plates and grown overnight at 37 ° c . phages are grown and processed as described by kramer et al . 2003 ( kramer et al . 2003 , nucleic acids res . 31 ( 11 ): e59 ) using vcsm13 as helper phage strain . elisa plates are coated with 100 microliters human recombinant il6 per well at a concentration of 2 . 5 micrograms / ml in pbs overnight at 4 ° c . plates coated with 100 microliters thyroglobulin at a concentration of 2 micrograms / ml in pbs are used as a negative control . wells are emptied , dried by tapping on a paper towel , filled completely with pbs - 4 % skimmed milk ( elk ) and incubated for one hour at room temperature to block the wells . after discarding the block solution , phage minipreps pre - mixed with 50 μl blocking solution are added and incubated for one hour at rt . unbound phages are subsequently removed by five washing steps with pbs - 0 . 05 % tween - 20 . bound phages are detected by incubating the wells with 100 microliters anti - m13 - hrp antibody conjugate ( diluted 1 / 5000 in blocking buffer ) for one hour at room temperature . free antibody is removed by repeating the washing steps as described above , followed by tmb substrate incubation until color development was visible . the reaction is stopped by adding 100 microliters of 2 m h2so4 per well and analyzed on an elisa reader at 450 nm emission wavelength . clones that give signals at least three times above the background signal are propagated , used for dna miniprep procedures ( see procedures qiagen miniprep manual ) and subjected to nucleotide sequence analysis . sequencing is performed according to the big dye 1 . 1 kit accompanying manual ( applied biosystems ) using a reverse primer ( ch1_rev1 , table 1 ) recognizing a 5 ′ sequence of the ch1 region of the human igg1 heavy chain ( present in the fab display vector mv1043 , fig3 and 12 ). the sequences of the murine vh regions are analyzed for diversity of dh and jh gene segments . vector mv1057 ( fig1 and 22 ) was generated by cloning the transgene ( igkv1 - 39 ) l chain fragment into a derivative of vector pcdna3000neo ( crucell , leiden , the netherlands ) that contains the human igg1 - and kappa constant regions . vh regions are cloned into mv 1057 and nucleotide sequences for all constructs are verified according to standard techniques . the resulting constructs are transiently expressed in hek293t cells and supernatants containing chimeric igg1 are obtained and purified using standard procedures as described before ( m . throsby 2006 , j . virol . 80 : 6982 - 92 ). igg1 antibodies are titrated in elisa using il6 - coated plates as described above and an anti - human igg peroxidase conjugate . competition elisas to group antibodies based on epitope recognition are performed by incubating fab phages together with igg1 or with commercial antibodies against il6 ( e . g ., abcam cat . no . ab9324 ) in il6 - coated plates , followed by detection of bound fab phage using an anti - m13 peroxidase conjugate . the affinities of the antibodies to il6 are determined with the quantitative kinetic protocol on the octet ( fortebio ). antibodies are captured onto an anti - human igg fc capture biosensor and exposed to free il6 and analyzed using proprietary software to calculate the kd of each antibody . to test the ability of the selected antibodies to inhibit binding between il6 and il6 receptor ( il6r ), an elisa based assay is used . various concentrations of antibody are mixed with a fixed concentration ( 10 ng / ml ) of biotinylated il6 as described by naoko et al . 2007 , can . res . 67 : 817 - 875 . the il6 - antibody immune complex is added to immobilized il6r . the binding of biotinylated il6 to il6r is detected with horseradish peroxidase - conjugated streptavidin . the reduction of elisa signal is a measurement of inhibition . as positive control for inhibition of binding between il6 and il6r either anti - il6r antibody ( abcam cat . no . ab34351 ; clone b - r6 ) or anti il6 antibody ( abcam cat . no . ab9324 ) is used . in vitro blocking activity of the selected anti - il6 antibodies is measured in a proliferation assay using the il6 - dependent cell line 7td1 . briefly , cells are incubated with different concentrations of human il6 with or without the anti - il6 antibody . the available amount of il6 determines the degree of proliferation . thus if an added antibody blocks il6 binding the proliferation readout is reduced compared to a non binding antibody control . proliferation is measured by the incorporation of 5 - bromo - 2 ′- deoxy - uridine ( brdu ) into the dna using the brdu proliferation kit ( roche cat . no . 11444611001 ) according to the manufacturer &# 39 ; s instructions . the most potent anti - il6 antibodies are selected from each epitope group . the expression constructs expressing these antibodies are transfected into hek293t cells in non - competing groups of three in different ratios ( 1 : 1 : 1 ; 3 : 1 : 1 ; 1 : 3 : 1 ; 1 : 1 : 3 ; 3 : 3 : 1 ; 1 : 3 : 3 ; 3 : 1 : 3 ; 10 : 1 : 1 ; 1 : 10 : 1 ; 1 : 1 : 10 ; 10 : 10 : 1 ; 1 : 10 : 10 ; 10 : 1 : 10 ; 3 : 10 : 1 ; 10 : 3 : 1 ; 1 : 10 : 3 ; 3 : 1 : 10 ; 10 : 1 : 3 ; 1 : 3 : 10 ). antibody containing supernatants are harvested and purified and characterized as above . to measure the ability of anti - il6 oligoclonics to form immune complexes and to analyze these complexes size exclusion chromatography ( sec ) is used according to the approach disclosed by min - soo kim et al . ( 2007 ), jmb 374 : 1374 - 1388 , to characterize the immune - complexes formed with different antibodies to tnfα . different molar ratios of the anti - il6 oligoclonics are mixed with human il6 and incubated for 20 hours at 4 ° c . or 25 ° c . the mixture is analyzed on an hplc system fitted with a size exclusion column ; different elution times are correlated to molecular weight using a molecular weight standards . the ability of antibodies to form complexes with il6 is correlated with their ability to rapidly clear the cytokine from the circulation in vivo . this is confirmed by measuring the clearance of radiolabelled il6 from mice . briefly , female , six - to eight - week - old balb / c mice are obtained and 18 hours before the experiment , the animals are injected intravenously ( iv ) via the lateral tail vein with different doses of purified anti - il6 oligoclonics . on day 0 , the mice are injected iv with 50 microliters of radiolabeled il - 6 ( 1 × 10e7 cpm / ml ) under the same conditions . blood samples ( approximately 50 microliters ) are collected at several time intervals and stored at 4 ° c . the samples are centrifuged for five minutes at 4000 xg and the radioactivity of the serum determined . all pharmacokinetic experiments are performed simultaneously with three animals for each treatment . a lead anti - il6 oligoclonic is selected based on the in vitro and in vivo potency as determined above . the murine vh genes are humanized according to standard methods and combined with the fully human igkv1 - 39 light chain in an expression vector as described above . examples of humanization methods include those based on paradigms such as resurfacing ( e . a . padlan et al . ( 1991 ), mol . immunol . 28 : 489 ), superhumanization ( p . tan , d . a ., et al . ( 2002 ), j . immunol . 169 : 1119 ) and human string content optimization ( g . a . lazar et al . ( 2007 ), mol . immunol . 44 : 1986 ). the three constructs are transfected into per . c6 cells at the predetermined optimal ratio ( described above ) under the selective pressure of g418 according to standard methods . a stable high producing anti - il6 oligoclonic clone is selected and a working and qualified master cell bank generated .
described are transgenic , non - human animals comprising a nucleic acid encoding an immunoglobulin light chain , whereby the immunoglobulin light chain is human , human - like , or humanized . the nucleic acid is provided with a means that renders it resistant to dna rearrangements and / or somatic hypermutations . in one embodiment , the nucleic acid comprises an expression cassette for the expression of a desired molecule in cells during a certain stage of development in cells developing into mature b cells . further provided is methods for producing an immunoglobulin from the transgenic , non - human animal .